Group 1 - The article discusses the IPO of Meidele, a leading supplier of intelligent conveyor systems in China, with an issuance price of 41.88 yuan and a total market value of 2.35 billion yuan [2][3] - The company has a primary revenue composition of 87.09% from modular conveyor systems and 12.91% from industrial components, serving major clients in the new energy battery and automotive sectors [2] - The company forecasts a revenue of 1.138 billion yuan for 2024, reflecting a growth of 12.78%, while the revenue for 2023 is projected at 1.009 billion yuan, showing a decline of 2.13% from the previous year [3] Group 2 - The article also covers the IPO of Zhenstone Co., which specializes in fiber-reinforced materials for the clean energy sector, with an issuance price of 11.18 yuan and a total market value of 16.54 billion yuan [5] - Zhenstone has established itself as a core supplier of fiber-reinforced materials for wind turbine blades, with 99% of its fiberglass procurement coming from China Jushi [5] - The company has developed photovoltaic frames that have passed TOV certification, demonstrating superior aging resistance and positioning itself as an early player in composite materials [5] Group 3 - The article mentions the IPO of Aisheren, the largest manufacturer of medical care pads in China, with an issuance price of 15.98 yuan and a total market value of 0.811 billion yuan [7] - Aisheren's core products excel in moisture permeability, water absorption, and load-bearing capacity, and the company has over 20 years of industry experience [7] - The aging global population presents significant growth opportunities for Aisheren's business in the future [7]

Group 1: New Stock Subscription - The new stock available for subscription today is Meidele, which focuses on the research, design, manufacturing, and sales of intelligent manufacturing equipment, particularly modular conveyor systems and industrial components [2][5] - Meidele's products are integrated with smart production equipment and are widely used in industries such as new energy, automotive parts, electronics, and logistics [2] - Major clients include leading companies in the industry such as BYD, CATL, and Xinzhi Group [2] Group 2: Financial Performance of Meidele - Meidele's projected revenues for 2022, 2023, and 2024 are 1.031 billion, 1.009 billion, and 1.138 billion yuan respectively, with net profits of 222.5 million, 205.2 million, and 210.8 million yuan [2] - For 2025, Meidele expects revenues between 1.3 billion and 1.4 billion yuan, representing a year-on-year growth of 14.26% to 23.05%, and net profits between 270 million and 300 million yuan, indicating a growth of 28.11% to 42.34% [2] Group 3: New Stock Listing - The new stock listed today is Aisheren, which is the largest manufacturer of medical care pads in China and a leading exporter of medical dressings [2][6] - Aisheren's projected revenues for 2022, 2023, and 2024 are 573.6 million, 574.7 million, and 691.6 million yuan respectively, with net profits of 62.8 million, 66.96 million, and 80.71 million yuan [3] - The company has a total market value of 1.082 billion yuan and is underwritten by Dongwu Securities [6]

Group 1: Company Overview of Meidel - Meidel, established in 2009, is a leading supplier of intelligent conveyor systems in China, focusing on the research, design, manufacturing, and sales of smart manufacturing equipment, particularly modular conveyor systems and industrial components [2][5] - The company’s products are integral to factory automation and are widely used in industries such as new energy, automotive parts, electronics, and warehousing logistics [5] - As of September 30, 2025, Meidel holds 201 patents, including 21 domestic invention patents and 159 utility model patents, and is recognized as a national high-tech enterprise [5] Group 2: Financial Metrics and Market Position of Meidel - Meidel's IPO price is set at 41.88 yuan per share, with an issuance price-to-earnings ratio of 14.99, compared to the industry average of 47.36 [3] - The company’s revenue and net profit for 2022 are projected to show a growth rate of 15% and 10% respectively, with a forecasted decline of 10% in 2024 [3][6] - The company plans to allocate 1.20 billion yuan (18.60%) to the Dalian Meidel Phase IV construction project and 2.00 billion yuan (31.01%) to the development of high-end intelligent conveyor systems [4] Group 3: Customer Base and Risks of Meidel - Meidel has a high customer concentration risk, with sales to the top five customers accounting for 59.34% of total revenue in 2022, which is projected to rise to 62.75% by mid-2025 [6] - The concentration is attributed to the high market concentration in the new energy battery sector, where leading companies have significant demand for conveyor systems [6] Group 4: Company Overview of Aishalon - Aishalon, founded in 2003, specializes in the research, production, and sales of disposable medical consumables in the rehabilitation and medical protection fields [7][11] - The company is recognized as the largest manufacturer of medical care pads in China and is rapidly advancing towards the top four in the industry [11] Group 5: Financial Metrics and Market Position of Aishalon - Aishalon's IPO price is set at 15.98 yuan per share, with an issuance price-to-earnings ratio of 14.99, compared to the industry average of 29.79 [8] - The company plans to invest 3.00 billion yuan (100%) into the Caprol public health medical supplies industrial park construction project [10] Group 6: Customer Base and Risks of Aishalon - Aishalon faces a high customer concentration risk, with sales to the top five customers making up 81.99% of total revenue in 2022, increasing to 88.40% by mid-2025 [12] - The primary customer, Medline Group, represents a significant portion of sales, with its share ranging from 71.51% to 77.73% over the forecast period [12]

今日爱舍伦(920050.BJ)上市，美德乐(920119.BJ)申购。 ...

Group 1 - The article highlights the popularity of new stocks on the Beijing Stock Exchange, with an estimated 1 trillion yuan expected to be invested in the upcoming IPOs, suggesting a conservative estimate of 700,000 applicants for 100 shares of Meidele [1] - Meidele's estimated subscription amount is projected to be 10,000 million yuan, with a public offering market value of 603 million yuan [2] - The estimated winning rate for Meidele's shares is approximately 0.060% [2] Group 2 - The article discusses the financial performance of a wealthy relative who achieved a 60% return on investments last year, indicating a trend of individuals turning to stock trading due to a lack of business opportunities [3] - The author mentions a strategy focused on dividend stocks, contrasting it with the relative's approach of investing in high-risk stocks [3] - The article notes the recent performance of convertible bonds, including announcements of strong redemptions and non-adjustments for specific bonds [5][7]

Investment Rating - The report maintains an "Accumulate" rating for the industry [1] Core Insights - The overall market performance of the North Exchange shows a significant increase, with the North 50 Index rising by 7.49% during the period from January 5 to January 16, 2026, closing at 1548.33 points. In comparison, the Shanghai and Shenzhen 300, ChiNext, and Sci-Tech 50 indices increased by 2.20%, 4.93%, and 12.64%, respectively [4][10] - The average market capitalization of the 288 constituent stocks in the North Exchange is 32.69 billion yuan, with a total market value of 941.449 billion yuan and a circulating market value of 573.460 billion yuan [1][4] - The daily average trading volume during this period reached 331.61 billion yuan, representing a 67.96% increase compared to the previous period [4][12] Summary by Sections North Exchange Market Overview - As of January 16, 2026, the North Exchange has 288 listed companies, with an average market capitalization of 32.69 billion yuan. The North 50 Index increased by 7.49% during the specified period [4][10] - The daily average trading volume was 331.61 billion yuan, with a turnover rate of 6.62%, which is an increase of 2.30 percentage points from the previous period [12][13] North Exchange Sector Performance - The top five performing sectors in the North Exchange during this period were Media (45.09%), Oil and Petrochemicals (22.23%), Non-ferrous Metals (16.87%), Automotive (14.64%), and Communications (13.47%) [4][15] North Exchange New Stocks - Three new stocks were issued during this period: Kema Materials (920086.BJ), Aisheren (920050.BJ), and Guoliang New Materials (920076.BJ) [5][23] North Exchange Key News - On January 5, 2026, the company Guangdao Tui (920680) was officially delisted, marking the first forced delisting due to major violations since the establishment of the North Exchange [7][24] - On January 14, 2026, the financing margin ratio for investors was adjusted from 80% to 100%, aimed at reducing leverage and protecting investors' rights [7][24] North Exchange Investment Strategy - The report suggests focusing on sectors expected to perform well in 2026, including Data Centers, Robotics, Semiconductors, Consumer Goods, and Military Information Technology [7][26]

Company Overview - The company specializes in medical dressings, focusing on two main categories, with over 70% of revenue coming from Medline Group[1] - Medline is the largest global manufacturer and distributor of surgical supplies, with an IPO raising approximately $6.264 billion to enhance its market presence[1] Financial Performance - Revenue growth is projected to accelerate, with 2024 revenue expected to increase by 20.4% year-on-year, reaching approximately 6.92 billion yuan[1] - Net profit for 2024 is anticipated to grow by 20.5% year-on-year, reaching around 0.81 billion yuan[1] Market Trends - The global low-value consumables market is expected to grow at a CAGR of 8.3% from 2024 to 2031, driven by factors such as aging population and rising chronic disease rates[1] - The domestic market for low-value consumables is projected to reach approximately 1280 billion yuan in 2023, with a CAGR of 14.8% from 2018 to 2023[1] Internationalization Strategy - The company is in a deepening phase of internationalization, focusing on core customer strategies and expanding production capacity overseas[1] - Key international clients include Medline, Zarys, and Sejong Healthcare, with a strong emphasis on maintaining high customer loyalty and competitive pricing[1] Risks - The company faces risks related to dependency on a single customer, fluctuations in raw material prices, and potential market competition intensification[1]

Investment Rating - The report indicates a strong enthusiasm for new stock offerings on the Beijing Stock Exchange (BSE), with a sufficient reserve of new stocks available for issuance [2][11]. Core Insights - In 2025, the BSE listed 26 new stocks, raising a total of 7.527 billion yuan, with a significant increase in issuance speed in the second half of the year. The amount of frozen funds for participating in new stock offerings nearly doubled from 451.8 billion yuan at the beginning of the year to 846.1 billion yuan by year-end [2][12]. - The average first-day price increase for newly listed stocks on the BSE remains high, sustaining investor enthusiasm for participating in new stock offerings. The report suggests that to stabilize allocation, investors should consider increasing their cash account size due to rising thresholds for stock acquisition [2][18]. - There are currently 210 new stocks awaiting approval on the BSE, with 28 already having passed the review process [19]. Summary by Sections New Stock Offerings on BSE - The BSE's new stock offerings have seen a significant increase in participation, with the total frozen funds rising dramatically throughout 2025. The report highlights that the minimum threshold for acquiring stocks has increased significantly, making it necessary for investors to allocate more funds to ensure stable allocations [2][12][19]. Recent New Stock Performance - The report tracks the performance of new stocks across various boards, indicating that the average first-day price increase for stocks on the Sci-Tech Innovation Board is 258.09%, while for the Growth Enterprise Market, it is 231.27% [31][38]. - The report also provides insights into the effective bidding account numbers for recent new stocks, showing a robust interest from investors [38]. Recent Market Trends - The report notes that the average return from participating in new stock offerings for A-class accounts with a scale of 200 million yuan is 3.82%, while for B-class accounts, it is 2.89% [25][32]. - The report emphasizes the importance of monitoring the performance of new stocks and suggests that investors should be aware of the potential for high returns, particularly in the current market environment [31][51].

IPO Review and Registration Progress - Six companies were reviewed for IPO last week, with five passing and one, Xinxing Technology, having its review postponed. The other companies that passed include Gaote Electronics, Lianxun Instruments, Tianhai Electronics, Ruier Jinda, and Zhongke Instruments [1][2] - Xinxing Technology, which specializes in computer embroidery machines, reported a revenue of 1.044 billion yuan for the first three quarters of 2025, a year-on-year increase of 44.48%, and a net profit of 150 million yuan, up 105.18% year-on-year. The company aims to raise approximately 449 million yuan through its IPO [1][2] - Gaote Electronics is set to be the first IPO on the Shenzhen Stock Exchange in 2026, focusing on automotive components. The review committee raised concerns about the company's declining gross margin and prolonged accounts receivable collection period [2][3] - Lianxun Instruments, the first company to pass on the Sci-Tech Innovation Board in 2026, specializes in electronic measurement instruments and semiconductor testing equipment. The review committee inquired about industry cycles and technology iterations [2][3] - Tianhai Electronics plans to list on the Shenzhen main board and aims to raise 2.46 billion yuan, the largest among last week's reviewed companies. The review committee focused on the sustainability of operating performance [3] - Ruier Jinda and Zhongke Instruments are also seeking to list on the Beijing Stock Exchange, with the committee questioning the authenticity of their performance and revenue recognition [3] Upcoming IPOs and Fundraising - This week, six companies are preparing for IPO, with Huikang Technology aiming to raise 1.797 billion yuan, the highest among them. Other companies include Aiteke and Liqi Intelligent, with planned fundraising of 1.5 billion yuan and 1 billion yuan, respectively [4][5] - Huikang Technology, which specializes in refrigeration equipment, reported steady revenue growth from 1.93 billion yuan in 2022 to 3.204 billion yuan in 2024, with net profit increasing from 197 million yuan to 451 million yuan [5][6] - Aiteke focuses on automotive electronic solutions and has a high customer concentration risk, particularly with Chery Automobile, which accounted for over 50% of its revenue in recent years [6] New Stock Listings and Subscription Dynamics - Two new stocks were listed last week, with Kema Materials seeing a significant increase of 371% on its first day. This week, one new stock, Aisheren, is set to be listed with an issue price of 15.98 yuan per share [8][9] - Aisheren, focused on medical health, expects to achieve revenue between 889 million yuan and 939 million yuan in 2025, representing a year-on-year growth of approximately 28.65% to 35.89% [8] - Three new stocks are scheduled for subscription this week, including Nongda Technology, which has an issue price of 25 yuan per share and anticipates revenue of 2.2 billion to 2.4 billion yuan in 2025 [10][11]

Core Insights - Two new stocks were issued today: Nongda Technology issued 16 million shares at a price of 25.00 yuan, raising 400 million yuan; Zhenstone Co. issued 261 million shares at a price of 11.18 yuan, raising 2.919 billion yuan [1][2] - As of January 19, a total of 7 companies have gone public this year, raising a cumulative amount of 6.828 billion yuan, with an average fundraising of 975 million yuan per company [1][2] Fundraising Overview - The fundraising amounts for the new stocks this year are as follows: - Zhenstone Co. raised the most at 2.919 billion yuan, primarily for the construction of fiberglass product production bases and composite material production bases [1] - Hengyun Chang raised 1.561 billion yuan for projects related to semiconductor and vacuum equipment core components [1] - Other notable fundraisers include C Zhixin (1.240 billion yuan), Nongda Technology (400 million yuan), and Aisheren (270 million yuan) [1] Issuance Price and Distribution - The average issuance price of new stocks this year is 26.95 yuan, with the highest price being 92.18 yuan for Hengyun Chang [2] - The geographical distribution of new stock issuances shows a concentration in Zhejiang, Shandong, and Jiangsu, with the highest fundraising amounts from Zhejiang (3.163 billion yuan), Guangdong (1.561 billion yuan), and Chongqing (1.240 billion yuan) [2]